The first phase of clinical trials of the coronavirus vaccine was completed, testing on a group of volunteers began in April. This was announced on Monday, May 18, by the American biotechnology company Moderna.
The company said in a statement that after taking mRNA-1273 vaccine the number of antibodies of the participants of the trials depending on the dosage of the drug or exceeded the corresponding figure in the blood of people with COVID-19, or was at the same level.
In the initial stage, the vaccine proved to be safe, and it is tolerated without complications. The company plans that the final stage of the trial will begin in July.
According to the latest data from Johns Hopkins University, the number of COVID-19 cases in the United States has exceeded 1.5 million.